The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Steven A. Rosenberg

Surgery Branch

National Cancer Institute

National Institutes of Health

CRC-Building 10

USA

[email]@nih.gov

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Surgery Branch, National Cancer Institute, National Institutes of Health, CRC-Building 10, USA. 1997 - 2011

References

  1. Cell transfer immunotherapy for metastatic solid cancer-what clinicians need to know. Rosenberg, S.A. Nat. Rev. Clin. Oncol (2011) [Pubmed]
  2. Of mice, not men: no evidence for graft-versus-host disease in humans receiving T-cell receptor-transduced autologous T cells. Rosenberg, S.A. Mol. Ther. (2010) [Pubmed]
  3. Different adjuvanticity of incomplete freund's adjuvant derived from beef or vegetable components in melanoma patients immunized with a peptide vaccine. Rosenberg, S.A., Yang, J.C., Kammula, U.S., Hughes, M.S., Restifo, N.P., Schwarz, S.L., Morton, K.E., Laurencot, C.M., Sherry, R.M. J. Immunother. (2010) [Pubmed]
  4. Adoptive cell therapy for the treatment of patients with metastatic melanoma. Rosenberg, S.A., Dudley, M.E. Curr. Opin. Immunol. (2009) [Pubmed]
  5. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Rosenberg, S.A., Restifo, N.P., Yang, J.C., Morgan, R.A., Dudley, M.E. Nat. Rev. Cancer (2008) [Pubmed]
  6. Overcoming obstacles to the effective immunotherapy of human cancer. Rosenberg, S.A. Proc. Natl. Acad. Sci. U.S.A. (2008) [Pubmed]
  7. Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines. Rosenberg, S.A., Sherry, R.M., Morton, K.E., Yang, J.C., Topalian, S.L., Royal, R.E., Kammula, U.S., Restifo, N.P., Hughes, M.S., Schwarz, S.L., Ngo, L.T., Mavroukakis, S.A., White, D.E. J. Immunother. (2006) [Pubmed]
  8. IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. Rosenberg, S.A., Sportès, C., Ahmadzadeh, M., Fry, T.J., Ngo, L.T., Schwarz, S.L., Stetler-Stevenson, M., Morton, K.E., Mavroukakis, S.A., Morre, M., Buffet, R., Mackall, C.L., Gress, R.E. J. Immunother. (2006) [Pubmed]
  9. Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma. Rosenberg, S.A., Sherry, R.M., Morton, K.E., Scharfman, W.J., Yang, J.C., Topalian, S.L., Royal, R.E., Kammula, U., Restifo, N.P., Hughes, M.S., Schwartzentruber, D., Berman, D.M., Schwarz, S.L., Ngo, L.T., Mavroukakis, S.A., White, D.E., Steinberg, S.M. J. Immunol. (2005) [Pubmed]
  10. Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes. Rosenberg, S.A., Dudley, M.E. Proc. Natl. Acad. Sci. U.S.A. (2004) [Pubmed]
  11. Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen. Rosenberg, S.A., Yang, J.C., Sherry, R.M., Hwu, P., Topalian, S.L., Schwartzentruber, D.J., Restifo, N.P., Haworth, L.R., Seipp, C.A., Freezer, L.J., Morton, K.E., Mavroukakis, S.A., White, D.E. Hum. Gene Ther. (2003) [Pubmed]
  12. Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanoma. Rosenberg, S.A., Yang, J.C., Robbins, P.F., Wunderlich, J.R., Hwu, P., Sherry, R.M., Schwartzentruber, D.J., Topalian, S.L., Restifo, N.P., Filie, A., Chang, R., Dudley, M.E. J. Immunother. (2003) [Pubmed]
  13. Identification of BING-4 cancer antigen translated from an alternative open reading frame of a gene in the extended MHC class II region using lymphocytes from a patient with a durable complete regression following immunotherapy. Rosenberg, S.A., Tong-On, P., Li, Y., Riley, J.P., El-Gamil, M., Parkhurst, M.R., Robbins, P.F. J. Immunol. (2002) [Pubmed]
  14. Progress in the development of immunotherapy for the treatment of patients with cancer. Rosenberg, S.A. J. Intern. Med. (2001) [Pubmed]
  15. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Rosenberg, S.A. Immunity (1999) [Pubmed]
  16. Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine. Rosenberg, S.A., Yang, J.C., Schwartzentruber, D.J., Hwu, P., Marincola, F.M., Topalian, S.L., Restifo, N.P., Sznol, M., Schwarz, S.L., Spiess, P.J., Wunderlich, J.R., Seipp, C.A., Einhorn, J.H., Rogers-Freezer, L., White, D.E. J. Immunol. (1999) [Pubmed]
  17. Cancer vaccines based on the identification of genes encoding cancer regression antigens. Rosenberg, S.A. Immunol. Today (1997) [Pubmed]
 
WikiGenes - Universities